Regional Business Manager - Denver
Intellia Therapeutics, Inc.
July 02, 2026
On-site
Cambridge, MA
Sales
How You Will Achieve More
Sales Representative to lead the commercial launch of an in vivo CRISPR therapy for hereditary angioedema (HAE). Territory covers Denver, CO.
Responsibilities
- Develop and execute territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers.
- Identify and prioritize high-value accounts (HAE patient volume, prescriber influence, institutional capabilities).
- Build trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers.
- Maintain a robust sales pipeline from initial awareness through patient treatment completion.
- Educate providers on in vivo CRISPR gene editing mechanisms and differentiate from ex vivo cell therapies and traditional treatments.
- Present Phase III efficacy and safety data; address misconceptions about CRISPR safety and differentiate from previous gene therapy launches.
- Maintain competitive intelligence; develop differentiated value propositions; proactively handle objections (CRISPR permanence and single-treatment cost).
- Educate on patient journey (from diagnosis confirmation through administration) and coordinate with patient support hubs.
- Partner with Medical Affairs/Medical Science Liaisons, Field Reimbursement Managers (payer strategy/coverage), and strategic accounts (referrals, site selection/activation).
Qualifications
- BS/BA in life sciences or business-related field.
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements.
- Comprehensive knowledge of HAE pathophysiology, treatment landscape, and unmet needs.
- Ability to analyze and present complex clinical trial data and real-world evidence.
- 5+ years specialty pharmaceutical sales experience (preferred: rare diseases, immunology, or genetic medicines).
- Proven rare disease commercialization experience; preferred: launch experience (first-in-class/novel mechanism).
- Demonstrated success in long sales cycles (12–18 months) with multiple stakeholders.
Skills/Attributes
- Exceptional scientific communication; relationship building; problem solving; collaboration; growth and competitive mindset; business-owner execution.
- Integrity, resilience, adaptability, patient focus.
Application Instructions
- Applications accepted on a rolling basis until the position is filled.
Sales Representative to lead the commercial launch of an in vivo CRISPR therapy for hereditary angioedema (HAE). Territory covers Denver, CO.
Responsibilities
- Develop and execute territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers.
- Identify and prioritize high-value accounts (HAE patient volume, prescriber influence, institutional capabilities).
- Build trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers.
- Maintain a robust sales pipeline from initial awareness through patient treatment completion.
- Educate providers on in vivo CRISPR gene editing mechanisms and differentiate from ex vivo cell therapies and traditional treatments.
- Present Phase III efficacy and safety data; address misconceptions about CRISPR safety and differentiate from previous gene therapy launches.
- Maintain competitive intelligence; develop differentiated value propositions; proactively handle objections (CRISPR permanence and single-treatment cost).
- Educate on patient journey (from diagnosis confirmation through administration) and coordinate with patient support hubs.
- Partner with Medical Affairs/Medical Science Liaisons, Field Reimbursement Managers (payer strategy/coverage), and strategic accounts (referrals, site selection/activation).
Qualifications
- BS/BA in life sciences or business-related field.
- Understanding of gene editing technologies, genetic medicines, and regulatory requirements.
- Comprehensive knowledge of HAE pathophysiology, treatment landscape, and unmet needs.
- Ability to analyze and present complex clinical trial data and real-world evidence.
- 5+ years specialty pharmaceutical sales experience (preferred: rare diseases, immunology, or genetic medicines).
- Proven rare disease commercialization experience; preferred: launch experience (first-in-class/novel mechanism).
- Demonstrated success in long sales cycles (12–18 months) with multiple stakeholders.
Skills/Attributes
- Exceptional scientific communication; relationship building; problem solving; collaboration; growth and competitive mindset; business-owner execution.
- Integrity, resilience, adaptability, patient focus.
Application Instructions
- Applications accepted on a rolling basis until the position is filled.